← Open Payments lookup

C. AMARA: Open Payments

NPI 1942265509 · PETERSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,088 in 113 payments from 16 companies in 2025. Trend: 2023 $1,358 · 2024 $1,847 · 2025 $2,088

Food & beverage: $2,088
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.13$282
Vanda Pharmaceuticals Inc.9$247
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)16$224
Neurocrine BioSciences, Inc.10$222
Teva Pharmaceuticals USA, Inc.13$169
Janssen Pharmaceuticals, Inc8$155
Otsuka America Pharmaceutical, Inc.10$150
Takeda Pharmaceuticals U.S.A., Inc.6$141
Lundbeck LLC5$90
Alkermes, Inc.4$84

Products named: COBENFY, FANAPT, CAPLYTA, INGREZZA, ABILIFY ASIMTUFII, TRINTELLIX, SPRAVATO, AUSTEDO XR.

Industry payments across VA — which companies pay providers there.